2009•Central Plains Medical JournalRequires access

Efficacy analysis of carvedilol in treatment of chronic heart failure

Junwei Liu

Open publisher page 0 citations

Abstract

Objective To observe the clinical therapeutic effect and safety of carvedilol in the treatment of chronic heart failure. Methods Sixty -eight cases of patients with chronic CHF were randomly divided into two groups:one group was received routine treatment (digitalis, diuretics, vasodilator, ACEI), and another group was received carvedilor (25 nag, bid × 90 d)as well as routine treatment. Results The treatment, efficiency in carvedilol group and control group were respectively 91.3% and 65.2% with significent difference between two groups, P <0. 01). No adverse reactions associated with carvedilol were observed. The improvements of HR, BP, LVEF, EDV, ESV after treatment in carvedilol group were significant (P < 0. 01 orP < 0. 05). Conclusions Adding carvedilol based on the routine therapy can improve the effect and the heart function. Carvedilol is a safe and effective drug. Key words: Carvedilol; Chronic congestive heart failure;  β adrenoceptor bloker

About this research paper

What this paper is about

Objective To observe the clinical therapeutic effect and safety of carvedilol in the treatment of chronic heart failure. Methods Sixty -eight cases of patients with chronic CHF were randomly divided into two groups:one group was received routine treatment (digitalis, diuretics, vasodilator, ACEI), and another group was received carvedilor (25 nag, bid × 90 d)as well as routine treatment. Results The treatment, efficiency in carvedilol group and control group were respectively 91.3% and 65.2% with significent difference between two groups, P <0. 01). No adverse reactions associated with carvedilol were observed. The improvements of HR, BP, LVEF, EDV, ESV after treatment in carvedilol group were significant (P < 0. 01 orP < 0. 05). Conclusions Adding carvedilol based on the routine therapy can improve the effect and the heart function. Carvedilol is a safe and effective drug. Key words: Carvedilol; Chronic congestive heart failure;  β adrenoceptor bloker

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical therapeutic effect and safety of carvedilol in the treatment of chronic heart failure. Methods Sixty -eight cases of patients with chronic CHF were randomly divided into two groups:one group was received routine treatment (digitalis, diuretics, vasodilator, ACEI), and another group was received carvedilor (25 nag, bid × 90 d)as well as routine treatment. Results The treatment, efficiency in carvedilol group and control group were respectively 91.3% and 65.2% with significent difference between two groups, P <0. 01). No adverse reactions associated with carvedilol were observed. The improvements of HR, BP, LVEF, EDV, ESV after treatment in carvedilol group were significant (P < 0. 01 orP < 0. 05). Conclusions Adding carvedilol based on the routine therapy can improve the effect and the heart function. Carvedilol is a safe and effective drug. Key words: Carvedilol; Chronic congestive heart failure;  β adrenoceptor bloker

Key concepts: Carvedilol, Medicine, Digitalis, Heart failure, Internal medicine, Cardiology, Vasodilation, Ejection fraction

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy analysis of carvedilol in treatment of chronic heart failure — Research Paper | ScholarLens